Thrombosis

touchCARDIO Future Leaders 2026 Following the successful introduction last year of our touchCARDIO Future Leaders, we are delighted to announce that nominations are now open for the 2026 edition. This initiative celebrates the next generation of pioneers in cardiology, those whose passion, ...

The ESC Congress 2025 congress was an important meeting for clinical practice guidance in cardiology, with several major societies releasing long-awaited updates. As always, clinical practice guidelines remain central to cardiology, ensuring that the latest trial data and real-world evidence are rapidly translated into consistent, evidence-based patient care. This year’s congress saw the unveiling of important new documents across prevention, acute care and long-term management, equipping cardiologists with refined decision pathways, updated risk-stratification tools and clearer benchmarks to optimise patient outcomes.

The touchCARDIO journal Heart International has once again seen an increase in its Journal Impact Factor (JIF), rising from 1.9 in 2024 to 2.3 in 2025.

Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.

touchCARDIO is delighted to announce that Heart International has received an impressive new Impact Factor of 1.9 in the 2024 Journal Citation Reports (JCR). This achievement marks a notable increase from last year’s Impact Factor of 0.2 and highlights the journal’s growing influence in the cardiology field.

touchCARDIO spoke with Dr Ganesan Karthikeyan All India Institute of Medical Sciences (AIIMS), New Delhi, India to get the results from the SAFE-PVT trial, presented at ESC 2024. SAFE-PVT was created to look at the difference in outcomes between surgery and fibrinolytic therapy to treat left-sided mechanical valve thrombosis, a condition that, while rare in developed countries, continues to affect patients in low- and middle-income countries where there are additional challenges in maintaining anticoagulation. This study looked to discern the differences in outcomes between surgery, the most common option in developed countries and also most recommended in Western guidelines, and fibrinolytic therapy with a low-dose, slow-infusion tPA regimen.

Watch an expert in thrombosis and haemostasis address reversal strategies in patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH).

Three experts discuss the management of complications of sickle cell disease, as well as recent advances in therapy.

The COVID-PACT study focused on critically ill patients with coronavirus disease 2019 (COVID-19), assessing the use of antithrombotic therapy. In this touchCARDIO interview, we speak with Dr David Berg (Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA) to discuss ...